Coverage of community-wide mass drug administration platforms for soil-transmitted helminths in Benin, India, and Malawi: findings from the DeWorm3 project

Arianna Rubin Means,Kristjana Hrönn Ásbjörnsdóttir,Katherine C. Sharrock,Sean R. Galagan,Kumudha Aruldas,Euripide Avokpaho,Félicien Chabi,Katherine E. Halliday,Parfait Houngbegnon,Gideon John Israel,Saravanakumar Puthupalayam Kaliappan,David Kennedy,Hugo Legge,William E. Oswald,Gokila Palanisamy,Elliott Rogers,Joseph Timothy,Emily Pearman,Rohan Michael Ramesh,James Simwanza,Jasmine Farzana Sheik-Abdullah,Mariyam Sheikh,Comlanvi Innocent Togbevi,Stefan Witek-McManus,Rachel L. Pullan,Robin Bailey,Khumbo Kalua,Moudachirou Ibikounlé,Adrian J. F. Luty,Sitara S. R. Ajjampur,Judd L. Walson
DOI: https://doi.org/10.1186/s40249-024-01241-0
2024-10-10
Infectious Diseases of Poverty
Abstract:Soil-transmitted helminths (STH) affect approximately 1.5 billion people globally. The current STH control strategy is annual or twice-annual preventive chemotherapy, typically school-based deworming targeting children and women of reproductive age. Mathematical modeling suggests that it may be possible to interrupt STH transmission through high-coverage community-wide mass drug administration (cMDA). DeWorm3 is a cluster randomized trial testing cMDA for prevalence reduction and transmission interruption. The purpose of this study is to describe coverage of cMDA in study clusters over time and correlates of coverage at individual and cluster levels.
infectious diseases,tropical medicine,parasitology
What problem does this paper attempt to address?